Antibodies are a stalwart tool in biomedical research. Most commonly used are animal-derived polyclonal and monoclonal antibodies (mAbs), and nonanimal-derived recombinant mAbs. According to Simon ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have now ...

Monoclonal antibodies target specific disease molecules. They can help treat cancer, autoimmune disorders, and infectious diseases. Discover what you should know about this therapy. Monoclonal ...

Monoclonal antibodies (mAbs) have been a key therapeutic option for non-communicable diseases for decades, and a small number of mAbs have helped treat infectious diseases, including COVID-19. The ...

Monoclonal antibodies were once the star of COVID-19 outpatient treatments. Since they first became available in 2020 – even before the first vaccines – more than 3.5 million infusions of the ...

There are a variety of therapies available compared to early in the pandemic. It's hard to imagine a time when treatments weren't available for COVID-19. Yet this was the case when the World Health ...

Monoclonal antibodies (mAbs) are a class of biologic drugs used to treat rheumatoid arthritis if other treatments aren’t effective. mAbs target specific parts of the immune system to reduce ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...

"Without it, I don't know how much worse I would have been," one patient said. Susan Eisen assumed her sore throat and headache would go away. Maybe she'd been working too hard, or not drinking enough ...

If you’ve tried other multiple myeloma treatments and they’re not working, your doctor may suggest immunotherapy. One type of immunotherapy uses monoclonal antibodies made in a lab to boost your ...

I n 2024, the U.S. Food and Drug Administration (FDA) approved the first monoclonal antibody for reducing food allergy reactions, including anaphylaxis, in adults and children age 1 year or older. The ...